CUTR - Cutera Receives Additional Approval from Health Canada for its truSculpt® iD Body Sculpting Technology
CUTERA®, INC., (Nasdaq: CUTR) ("Cutera" or the "Company") a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced today that Health Canada recently granted regulatory approval expanding the indications for use for truSculpt® iD to include reduction of circumference of the abdomen and non-invasive lipolysis (the permanent removal of fat cells).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190912005123/en/
Before and After with truSculpt® iD Body Sculpting Technology (Photo: Business Wire)
"Canada is a key market for Cutera and our full aesthetics technology product line," said Cutera's Chief Executive Officer, David Mowry. “truSculpt iD’s global popularity among providers and patients remains strong. This additional approval from Health Canada reinforces the acknowledgement of the clinical effectiveness for truSculpt iD to permanently eliminate fat.”
Research shows that noninvasive body sculpting is the #1 non-surgical fat reduction procedure, with a 14.5% increase year-over-year in body shaping procedures.1,2
The Company launched truSculpt iD in the US and Canada in 2018.
About truSculpt iD
truSculpt is a non-surgical body sculpting treatment that uses monopolar radiofrequency (RF) technology. It is clinically proven to get rid of stubborn fat cells permanently by an average of 24%3, even in areas that are resistant to diet and exercise. truSculpt iD is clinically proven to eliminate fat in as little as one 15-minute hands-free treatment, completely personalized to an individual's needs.
Additional information can be found:
trusculpt.com
cutera.com/trusculptiD
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call +1 415-657-5500 or 1-888-4CUTERA or visit cutera.com.
Sources:
- American Society for Aesthetic Plastic Surgery
- Medical Insight (MII)
- Amy Taub, MD, Study ASDS 2017 Poster
View source version on businesswire.com: https://www.businesswire.com/news/home/20190912005123/en/
Tanya Rodante
Director of Corporate Communications
+1 415-657-5500
trodante@cutera.com